380843-75-4 Bosutinib
| Nom |
Bosutinib |
| Nom anglais |
Bosutinib; 4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile; 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile; 3-Quinolinecarbonitrile, 4-[(2,4-dichloro-5-Methoxyphenyl)amino]-6-Methoxy-7-[3-(4-Methyl-1-piperazinyl)propoxy]-; SKI-606 |
| Formule moléculaire |
C26H29Cl2N5O3 |
| Poids Moléculaire |
530.4462 |
| InChI |
InChI=1/C26H29Cl2N5O3/c1-32-6-8-33(9-7-32)5-4-10-36-25-13-21-18(11-24(25)35-3)26(17(15-29)16-30-21)31-22-14-23(34-2)20(28)12-19(22)27/h11-14,16H,4-10H2,1-3H3,(H,30,31) |
| Numéro de registre CAS |
380843-75-4 |
| Structure moléculaire |
|
| Densité |
1.36g/cm3 |
| Point de fusion |
116-120℃ |
| Point d'ébullition |
649.7°C at 760 mmHg |
| Indice de réfraction |
1.651 |
| Point d'éclair |
346.7°C |
| Pression de vapeur |
9.15E-17mmHg at 25°C |
|